Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases.

Sundararajan T, Manzardo AM, Butler MG.

Gene. 2018 Jan 30;641:25-34. doi: 10.1016/j.gene.2017.10.035. Epub 2017 Oct 13.

PMID:
29032150
2.

The molecular genetic architecture of attention deficit hyperactivity disorder.

Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W, Bellgrove MA.

Mol Psychiatry. 2015 Mar;20(3):289-97. doi: 10.1038/mp.2014.183. Epub 2015 Jan 20. Review.

PMID:
25600112
3.

Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder.

Akutagava-Martins GC, Salatino-Oliveira A, Genro JP, Contini V, Polanczyk G, Zeni C, Chazan R, Kieling C, Anselmi L, Menezes AM, Grevet EH, Bau CH, Rohde LA, Hutz MH.

Am J Med Genet B Neuropsychiatr Genet. 2014 Sep;165B(6):502-9. doi: 10.1002/ajmg.b.32253. Epub 2014 Jul 2.

4.

mGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion.

Jew CP, Wu CS, Sun H, Zhu J, Huang JY, Yu D, Justice NJ, Lu HC.

PLoS One. 2013 Aug 5;8(8):e70415. doi: 10.1371/journal.pone.0070415. Print 2013.

5.

Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD.

Lesch KP, Merker S, Reif A, Novak M.

Eur Neuropsychopharmacol. 2013 Jun;23(6):479-91. doi: 10.1016/j.euroneuro.2012.07.013. Epub 2012 Aug 30. Review.

PMID:
22939004
6.

Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.

Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H, Kim CE, Robison R, Lyon GJ, Flory JH, Bradfield JP, Imielinski M, Hou C, Frackelton EC, Chiavacci RM, Sakurai T, Rabin C, Middleton FA, Thomas KA, Garris M, Mentch F, Freitag CM, Steinhausen HC, Todorov AA, Reif A, Rothenberger A, Franke B, Mick EO, Roeyers H, Buitelaar J, Lesch KP, Banaschewski T, Ebstein RP, Mulas F, Oades RD, Sergeant J, Sonuga-Barke E, Renner TJ, Romanos M, Romanos J, Warnke A, Walitza S, Meyer J, Pálmason H, Seitz C, Loo SK, Smalley SL, Biederman J, Kent L, Asherson P, Anney RJ, Gaynor JW, Shaw P, Devoto M, White PS, Grant SF, Buxbaum JD, Rapoport JL, Williams NM, Nelson SF, Faraone SV, Hakonarson H.

Nat Genet. 2011 Dec 4;44(1):78-84. doi: 10.1038/ng.1013.

7.

Genome-wide association study in German patients with attention deficit/hyperactivity disorder.

Hinney A, Scherag A, Jarick I, Albayrak Ö, Pütter C, Pechlivanis S, Dauvermann MR, Beck S, Weber H, Scherag S, Nguyen TT, Volckmar AL, Knoll N, Faraone SV, Neale BM, Franke B, Cichon S, Hoffmann P, Nöthen MM, Schreiber S, Jöckel KH, Wichmann HE, Freitag C, Lempp T, Meyer J, Gilsbach S, Herpertz-Dahlmann B, Sinzig J, Lehmkuhl G, Renner TJ, Warnke A, Romanos M, Lesch KP, Reif A, Schimmelmann BG, Hebebrand J; Psychiatric GWAS Consortium: ADHD subgroup.

Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(8):888-97. doi: 10.1002/ajmg.b.31246. Epub 2011 Oct 19.

PMID:
22012869
8.

[Fragile X, fulminant hepatitis: new hope].

Nau JY.

Rev Med Suisse. 2011 Feb 16;7(282):418-9. French. No abstract available.

PMID:
21416872
9.

Fragile X syndrome -- from genes to cognition.

Schneider A, Hagerman RJ, Hessl D.

Dev Disabil Res Rev. 2009;15(4):333-42. doi: 10.1002/ddrr.80.

PMID:
20014363
10.

Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.

Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'arcy M, deBerardinis R, Frackelton E, Kim C, Lantieri F, Muganga BM, Wang L, Takeda T, Rappaport EF, Grant SF, Berrettini W, Devoto M, Shaikh TH, Hakonarson H, White PS.

Mol Psychiatry. 2010 Jun;15(6):637-46. doi: 10.1038/mp.2009.57. Epub 2009 Jun 23. Erratum in: Mol Psychiatry. 2010 Nov;15(11):1122.

Supplemental Content

Loading ...
Support Center